BiotechTube

TNX-102 SL Tablet 2.8 mg

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Primary Fibromyalgia

Conditions

Primary Fibromyalgia

Trial Timeline

Aug 4, 2015 → Sep 28, 2016

NCT ID
NCT02589275

About TNX-102 SL Tablet 2.8 mg

TNX-102 SL Tablet 2.8 mg is a phase 3 stage product being developed by Tonix Pharmaceuticals for Primary Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT02589275. Target conditions include Primary Fibromyalgia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02589275Phase 3Completed

Competing Products

20 competing products in Primary Fibromyalgia

See all competitors
ProductCompanyStageHype Score
Unfractionated heparinSinopharmPre-clinical
22
azenosertibZentalis PharmaceuticalsPhase 2
44
Latanoprost plus adjunctive glaucoma medicationSight SciencesApproved
77
REN001OnKure TherapeuticsPhase 1
25
Mavodelpar + PlaceboOnKure TherapeuticsPhase 2
44
REN001OnKure TherapeuticsPhase 2/3
57
SBI-100 Ophthalmic Emulsion, 0.5% + SBI-100 Ophthalmic Emulsion, 1.0% + SBI-100 Ophthalmic Emulsion, PlaceboSkye BiosciencePhase 2
44
Rituximab + Methotrexate + Cytarabine InjectionCelltrionPhase 2
52
Rituximab, lenalidomideCelltrionPhase 2
52
ibandronic acid 0.5mg + RIS placebo + 1.0mg ibandronic acid + ibandronic acid placebo + 2.5mg RISChugai PharmaceuticalPhase 3
77
CS-3150Daiichi SankyoPre-clinical
23
Bempedoic acid + Ezetimibe + Rosuvastatin + AtorvastatinDaiichi SankyoPre-clinical
23
Bempedoic acid 180 mg tabletDaiichi SankyoApproved
85
Combination of bempedoic acid and ezetimibeDaiichi SankyoPre-clinical
23
DS-8201a + T-DM1Daiichi SankyoPhase 3
77
Bempedoic acid and/or its fixed dose combination with ezetimibeDaiichi SankyoPre-clinical
23
Roxadustat + PlaceboAstellas PharmaPhase 3
77
Enzalutamide + ExemestaneAstellas PharmaPhase 2
52
Bocidelpar + PlaceboAstellas PharmaPhase 2
52
Methotrexate + Ibrutinib + TemozolomideSun PharmaceuticalPhase 2
52

Other Products from Tonix Pharmaceuticals

TNX-102 SLPhase 3
69
TNX-102 SL 5.6 mgPhase 3
69
TNX-102 SL Tablet, 2.8 mg + Placebo SL TabletPhase 3
69
TNX-102 SL Tablet, 2.8mg + Placebo SL TabletPhase 3
69
TNX-102 SL + Placebo SL TabletPhase 3
69